Mergers & Acquisitions

BGC Re-affirms Offer To Acquire GFI For $6.10 Per Share In Cash

BGC Re-affirms Offer To Acquire GFI For $6.10 Per Share In Cash BGC Sends Executed Agreement Which Includes Terms Obligating BGC to Complete $6.10 per Share Tender Offer if CME Merger Vote Fails and GFI Countersigns ISS Issues an Additional Note on the Proposed GFI Management-CME Merger Further Highlighting What ISS has Deemed “Significant Conflicts of Interest” ISS and Glass Lewis Recommend that GFI Shareholders Vote AGAINST the Inferior CME/GFI Management Transaction; ISS Further Recommends Tendering Shares to BGC PR Newswire NEW YORK, Jan. 29, 2015 NEW YORK , Jan. 29, 2015 /PRNewswire/ — BGC Partners, Inc […]

Momentum Stocks

Bear of the Day: Freeport McMoran (FCX) – Bear of the Day

Snakebit: adjective -,bit – having bad luck: very unlucky You can add another definition to the word snakebit here, and it’s not the phrase “Bear of the Day” which this snakebit stock is. No, you only need to add the company name, Freeport McMoran Copper & Gold ( FCX) . As if it wasn’t bad enough to be a gold miner over the course of the last couple of years, FCX tried, in vain, to hedge its metals exposure by getting into another very popular commodity […]

Stock Analysts

Harris Wins Contract for Vehicle Communication Systems

Leading supplier of communications equipment and services, Harris Corporation ( HRS ), has received an order from the Air National Guard (ANG) to provide essential ground-to-air communications solutions during war and natural calamities, as well as for household crisis. The five-channel vehicle communication systems leverage Harris’ expertise in wideband tactical radios and systems integration abilities to make available vital information across the operational region. It would thus facilitate better synchronization and alliance between ANG and the local authorities by providing them enhanced command, control and situational awareness […]

Stock Analysts

Teva Gains FDA Nod for Generic of AstraZeneca’s Nexium

While the worst of the patent cliff is over for the pharma sector, there are still some companies that are slated to lose exclusivity for key products and face generic competition in the coming years. One such company is AstraZeneca ( AZN ) – the first generic version of its blockbuster heartburn drug, Nexium delayed-release capsules has been approved by the FDA. Teva Pharmaceutical Industries Ltd. […]

Stock Analysts

Synageva Starts Dosing in Phase I/II Study for Sanfilippo B

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. Additionally, with pipeline updates, companies sometimes provide updates on the regulatory front including events like new designations for their candidates, filing of marketing applications or acceptance of these applications for review by regulatory agencies. These updates provide information on experimental drugs and at times give an insight on the commercial potential of the candidate once it is successfully developed and commercialized. […]

Stock Analysts

Will Abbott Labs (ABT) Disappoint on Earnings This Quarter?

Abbott Laboratories ( ABT ) is scheduled to report fourth-quarter 2014 results before the opening bell on Jan 29, 2015. Abbott Labs’ track record was impressive in the first nine months of 2014 with the company beating estimates comfortably in the last three quarters. The average earnings surprise over the last four quarters is 6.59% […]

Stock Analysts

Obama Open to Offshore Atlantic Exploration: Drillers Delighted

On Tuesday, the Obama administration put forth a proposal to allow drilling in the federally owned waters off the Atlantic coast for the first time. The plan, however, closed doors to some regions off the Alaskan coast. The proposal, which tends to strike a balance between coastal energy development and protection of sensitive environment, drew complements and comments of equal footing […]

Stock Analysts

Is AbbVie (ABBV) Set to Beat 4Q Earnings on Humira Sales?

AbbVie ( ABBV ), which has been in the news thanks to the recent approval of its hepatitis C virus (HCV) treatment Viekira Pak, will be reporting fourth quarter and full year 2014 results on Jan 30, before the market opens. AbbVie’s performance has been pretty good in the first nine months of 2014 with the company beating expectations consistently. The average earnings surprise over the last four quarters is +6.67% […]

Stock Analysts

Cliffs Natural (CLF) to Restructure Bloom Lake Mine

Cliffs Natural Resources Inc. ( CLF ) said that Bloom Lake General Partner Limited and certain of its affiliates, including Cliffs Quebec Iron Mining ULC (collectively called Bloom Lake Group) have started restructuring proceedings in Montreal, Quebec, under the Companies' Creditors Arrangement Act (Canada) ("CCAA"). The Bloom Lake group had previously suspended operations and has been looking for opportunities to sell some of its Canadian assets. […]